SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-16-065820
Filing Date
2016-11-02
Accepted
2016-11-02 13:44:06
Documents
2
Period of Report
2016-11-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3825
2 POWER OF ATTORNEY (PUBLIC): BRENNAN POA doc1.txt EX-24 3912
  Complete submission text file 0001127602-16-065820.txt   9154
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Issuer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INSYS THERAPEUTICS, INC 1333 SOUTH SPECTRUM BLVD, SUITE 100 CHANDLER AZ 85286
Business Address
BRENNAN DANIEL (Reporting) CIK: 0001657999 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37568 | Film No.: 161967061